Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

NCT05794217 is registered in ClinicalTrials.gov with Sanguine Biosciences as lead sponsor.

NCT NCT05794217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05794217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
Lead sponsor
Sanguine Biosciences
Phase
Observational
Overall status
Recruiting
Start date
September 28, 2022
Completion date
December 31, 2026
Enrollment
20,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rare diseases